Global Report Life Sciences

Cancer Biomarkers Market—Global Forecast 2026

consainsights.com
Cancer Biomarkers Market by Biomarker Type, Cancer Type, Profiling Technology, Application, Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.

Executive Summary

The global cancer biomarkers market size is expected to grow from USD 15.68 billion in 2020 to USD 28.19 billion by 2026 at a CAGR of 10.3%.

Over the past few years, fields, such as photography, immunoassays, omics technology, and bioinformatics have seen great advances in technology. In addition, several companies working in the imaging market are focused on building high-tech technology that is more economical, offers better patient safety, and is easier to use.

Advances in omics technology enable faster discovery of genomic, proteomic, and metabolomic data, and its integration with clinical trial data using advanced bioinformatics software. Evolution in advanced genomic technology contributes to the identification and analysis of mutations and polymorphisms in important genes, thereby increasing the range of available organisms. For example, researchers at the Mayo Clinic have found a role in changes in the type of SPOP in building BET resistance. With this development, the number of genomic biomarkers available for cancer diagnosis is expected to increase.

Many epidemiology studies use biomarkers to investigate different stages of disease in humans. This requires careful management and retention of valuable samples to obtain more information from limited samples and to reduce future research costs through banking samples. Sample collection is therefore one of the most important aspects of service providers, followed by access to these samples. Strict quality control of these samples is required and needs to be maintained under appropriate conditions to avoid any losses. Also, different samples are required for risk detection, testing, diagnosis, and monitoring procedures.

The validity of results from biomarkers studies using stored specimens depends on the integrity of the species and how they are collected, processed, and stored. In addition to sample storage, specimen banks should be organized so that all aspects of patient rights, privacy, and confidentiality are addressed with full informed consent and take into account the possible use of samples. In addition, detailed tracking, template retention, and retrieval software are required for proper sample handling. These problems are expected to hinder the growth of the entire cancer market.

Over the years, the popularity of customized drugs has skyrocketed, thanks to standard diagnostic and therapeutic restrictions. The various fields of medicine, from cancer to psychology, focus on the treatment of each patient based on its natural and clinical characteristics. The use of biomarkers has played a very important role in certain aspects of the drug made for you. Also, the value of biomarkers is increasing in the field of customized medicine, with applications available for diagnosis, prognosis, and choice of targeted therapies. In terms of quantifying the risk of disease and responding to treatment, continuous development and identification of disease-specific biomarkers and individual patients is important in human-based medicine. Therefore, the field of customized medicine is expected to provide potential growth opportunities for athletes working in the market for cancer biomarkers.

Despite the advances of biomarkers over the past few years, the lack of clarity regarding several basic factors hinders their full potential in human medicine. The limited acceptance of intensive clinical trials is one of the major challenges in this regard. Human diseases are complex; many biomarkers are needed to explain the imbalance of the immune system that causes the disease and the effect of treatment. The biomarker verification process includes experimental testing or measurement of performance factors, such as sensitivity, specificity, and reproduction.

The genetic biomarker is expected to register the highest CAGR during the forecast period. The growth of this market segment is driven by the development of technology to detect genetic mutations. Next-generation sequencing (NGS), gene expression profiling (microarray), and polymerase chain reaction (PCR) are the major technologies used for biomarker detection and diagnosis. Advances in high-performance technologies are the driving force behind the genetic market. Over the years, key players in the market have introduced many high-tech products, which have improved the speed and accuracy of the discovery and diagnosis of the genetic biomarker.

The lung cancer segment is expected to register the highest CAGR during the forecast period. The increase in the automatic portion of the blood collection can be attributed to an increase in the number of new cases of lung cancer. Increasing the company's focus on research on lung cancer biomarkers is one of the key drivers in this market. Increased understanding of the morphology of lung carcinogenesis, the development of advanced biomarker detection techniques, and increased focus on early detection of cancer also promote the growth of this market

Bioinformatics helps in the identification of the most powerful and biologically active biomarkers. Data mining also provides translation and testing tools for predicting and predicting models as well as ways to support the use of predictive descriptive processes. This results in the growth of this category. In addition, technological advances, the need for new drug formulations and clinical trials, as well as the growing information technology industry in developing countries, such as India and China, are the leading bioinformatics applications in the discovery and development of biomarkers.

The discovery of Biomarker-enabled drugs helps to better understand diseases during targeted discovery. It plays a major role in guiding decisions at all stages of drug development - from drug discovery and preclinical testing to clinical trials - and has therefore become an important tool in the development of effective drugs. The use of biomarkers helps to ensure the effectiveness and safety of those seeking drug use, understanding their mechanisms, and determining the effective dose regime. This results in the growth of this category.

Growth in the developed markets of North America and Europe is strongly influenced by the high adoption of advanced technologies such as NGS, the increase in the number of research studies on the discovery and development of novel biomarkers, the availability of a large number of pharmaceutical companies, the increase in investment and investment from public and private organizations. of patients and drug development.

The key players of the global cancer biomarkers market are Thermo Fisher Scientific, Bio-Rad Laboratories, Qiagen N.V., Agilent Technologies, Illumina, GE Healthcare, Roche Diagnostics, Biomérieux SA, Merck & Co., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Sysmex Corporation, Myriad Genetics, Quest Diagnostics, and Hologic.

Global Cancer Biomarkers Market Size, 2017-2026 (USD Billion)
Global Cancer Biomarkers Market Size, By Region, 2017-2026 (USD Billion)
Global Cancer Biomarkers Market Revenue Share (%), By Biomarker Type (2020)
Global Cancer Biomarkers Market Revenue Share (%), By Cancer Type (2020)
Global Cancer Biomarkers Market Revenue Share (%), By Profiling Technology (2020)
Global Cancer Biomarkers Market Revenue Share (%), By Application (2020)
Global Cancer Biomarkers Market Revenue Share (%), By Region (2020)

Market Overview

Definition & Scope

Cancer biomarkers are substances or processes that indicate the presence of cancer in the human body. Biomarkers can be produced by cancer cells themselves or by other cells in the body in response to cancer. They are found in blood, feces, urine, body tissues, or other tissues or body fluids. They improve cancer detection and simplify slow-moving diagnoses using genomics and proteomics.

Currency, Year & Forecasts Overview

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD.
For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.
The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

Industry Analysis

Unlock all the content, buy full report now.

Buy Full Report

Market Analysis

Unlock all the content, buy full report now.

Buy Full Report

By Biomarker Type

Global Cancer Biomarkers Market Size, By Biomarker Type, 2017-2026 (USD Billion)
Protein Biomarkers Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Genetic Biomarkers Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Other Cancer Biomarkers Market Size, 2017 vs 2020 vs 2026 (USD Billion)

By Cancer Type

Global Cancer Biomarkers Market Size, By Cancer Type, 2017-2026 (USD Billion)
Breast Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Lung Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Colorectal Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Prostate Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Non-Hodgkin’s Lymphoma Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Melanoma Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Leukemia Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Thyroid Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Bladder Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Kidney Cancer Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Other Cancer Types Market Size, 2017 vs 2020 vs 2026 (USD Billion)

By Profiling Technology

Global Cancer Biomarkers Market Size, By Profiling Technology, 2017-2026 (USD Billion)
Omics Technologies Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Proteomics Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Genomics Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Other Omics Technologies Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Imaging Technologies Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Immunoassays Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Cytogenetics Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Bioinformatics Market Size, 2017 vs 2020 vs 2026 (USD Billion)

By Application

Global Cancer Biomarkers Market Size, By Application, 2017-2026 (USD Billion)
Diagnostics Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Research and Development Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Prognostics Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Risk Assessment Market Size, 2017 vs 2020 vs 2026 (USD Billion)
Other Applications Market Size, 2017 vs 2020 vs 2026 (USD Billion)

North America

Unlock all the content, buy full report now.

Buy Full Report

Europe

Unlock all the content, buy full report now.

Buy Full Report

Asia Pacific

Unlock all the content, buy full report now.

Buy Full Report

Middle East & Africa

Unlock all the content, buy full report now.

Buy Full Report

Latin America

Unlock all the content, buy full report now.

Buy Full Report

Company Analysis

Thermo Fisher Scientific

Thermo Fisher Scientific was founded in 1956 and is headquartered in Massachusetts, US. Its employee strength is 80,000. The company has direct presence across the regions of North America, Europe, Asia Pacific, Middle East and Africa, and South America. It is a leading global supplier of life sciences technologies and solutions. Thermo Fisher Scientific enables its customers to make the world cleaner, safer, and healthier. Thermo Fisher Scientific serves over 400,000 customers from the fields of pharmaceuticals, biotech, hospitals, clinics, diagnostic labs, universities, research institutes, and government.

Cancer Cell Analysis: Cancer Biomarker

Competitive Analysis

Unlock all the content, buy full report now.

Buy Full Report

Analyst Insights For Success

Unlock all the content, buy full report now.

Buy Full Report

Research Methodology

This research study involved the usage of extensive secondary sources, directories, and databases such a Hoovers, Bloomberg Business, Factiva, and Avention, in order to identify and collect information useful for this technical, market-oriented, and commercial study of the global cancer biomarkers market. The primary sources were mainly industry experts from the core and related industries. These include service providers, technology developers, standards and certification organizations, and organizations related to all segments of the value chain.

In-depth interviews were conducted with various primary respondents, which include key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as to assess future prospects.

Various secondary sources were referred to for the identification and collection of information for this study. Secondary sources include annual reports, press releases, and investor presentations of companies, white papers, medical journals, certified publications, articles from recognized authors, gold standard and silver standard websites, directories, and databases.

Secondary research was mainly used to obtain key information about the industry’s supply chain, market’s monetary chain, the total pool of key players, market classification and segmentation according to industry trends to the bottom-most level, geographical markets, and key developments from both market-and technology-oriented perspectives.

After the market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation) was completed, extensive primary research was conducted to verify and validate the critical numbers arrived at. Primary research was also conducted to identify the segmentation types; industry trends; key players; the competitive landscape of global cancer biomarkers market; and key market dynamics such as drivers, restraints, opportunities, challenges, and key industry trends.

In the complete market engineering process, both top-down and bottom-up approaches were extensively used along with several data triangulation methods to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report.

Appendix

Available Customisations

With this full-market report, Consainsights offers customization options to our clients.
Custom Research: Consainsights offers custom research services across the Industries we track. In case of any custom research requirement, please send your inquiry at sales@consainsights.com

Related Reports

Biomarkers Market
Cancer Tumor Profiling Market
Breast Cancer Liquid Biopsy Market
Cancer Diagnostics Market
Patient Derived XenograftPDX Model Market
Biomarker Technologies Market

Overview

Cancer Biomarkers Market from Consainsights analyses the Cancer Biomarkers Market in the Life Sciences industry over the forecast period to 2026.

Cancer Biomarkers research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Cancer Biomarkers segmentation includes Biomarker Type, Cancer Type, Profiling Technology, Application and Geography.

Market analysis on the basis of Biomarker Type include Protein Biomarkers, Genetic Biomarkers, Other Cancer Biomarkers. This segmentation encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the Cancer Type, the Cancer Biomarkers Market analysis covers Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Non-Hodgkin’s Lymphoma, Melanoma, Leukemia, Thyroid Cancer, Bladder Cancer, Kidney Cancer, Other Cancer Types.

Based on the Profiling Technology, the Cancer Biomarkers Market analysis covers Omics Technologies, Proteomics, Genomics, Other Omics Technologies, Imaging Technologies, Immunoassays, Cytogenetics, Bioinformatics.

Based on the Application, the Cancer Biomarkers Market analysis covers Diagnostics, Research and Development, Prognostics, Risk Assessment, Other Applications.

Key companies operating in the market include Thermo Fisher Scientific, Bio-Rad Laboratories, Roche Diagnostics, Qiagen N.V., Illumina, GE Healthcare, Agilent Technologies and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

The Cancer Biomarkers Market is segmented into the following categories:

Cancer Biomarkers Market by Biomarker Type:

  • Protein Biomarkers
  • Genetic Biomarkers
  • Other Cancer Biomarkers

Cancer Biomarkers Market by Cancer Type:

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Non-Hodgkin’s Lymphoma
  • Melanoma
  • Leukemia
  • Thyroid Cancer
  • Bladder Cancer
  • Kidney Cancer
  • Other Cancer Types

Cancer Biomarkers Market by Profiling Technology:

  • Omics Technologies
  • Proteomics
  • Genomics
  • Other Omics Technologies
  • Imaging Technologies
  • Immunoassays
  • Cytogenetics
  • Bioinformatics

Cancer Biomarkers Market by Application:

  • Diagnostics
  • Research and Development
  • Prognostics
  • Risk Assessment
  • Other Applications

Table of Contents

  1. Executive Summary

  2. Cancer Biomarkers Market Overview

    1. Cancer Biomarkers Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Cancer Biomarkers Market 360° Synopsis: Overview
  3. Cancer Biomarkers Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Cancer Biomarkers Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Cancer Biomarkers Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Cancer Biomarkers Market: Biomarker Type

    1. Introduction
    2. Protein Biomarkers: Market Trends, Size, and Forecast (2017-2026)
    3. Genetic Biomarkers: Market Trends, Size, and Forecast (2017-2026)

      1. Lung Cancer
      2. Colorectal Cancer
      3. Breast Cancer
      4. Prostate Cancer
      5. Leukemia
    4. Other Cancer Biomarkers: Market Trends, Size, and Forecast (2017-2026)
  6. Cancer Biomarkers Market: Cancer Type

    1. Introduction
    2. Breast Cancer: Market Trends, Size, and Forecast (2017-2026)
    3. Lung Cancer: Market Trends, Size, and Forecast (2017-2026)
    4. Colorectal Cancer: Market Trends, Size, and Forecast (2017-2026)
    5. Prostate Cancer: Market Trends, Size, and Forecast (2017-2026)
    6. Non-Hodgkin’s Lymphoma: Market Trends, Size, and Forecast (2017-2026)
    7. Melanoma: Market Trends, Size, and Forecast (2017-2026)
    8. Leukemia: Market Trends, Size, and Forecast (2017-2026)
    9. Thyroid Cancer: Market Trends, Size, and Forecast (2017-2026)
    10. Bladder Cancer: Market Trends, Size, and Forecast (2017-2026)
    11. Kidney Cancer: Market Trends, Size, and Forecast (2017-2026)
    12. Other Cancer Types: Market Trends, Size, and Forecast (2017-2026)
  7. Cancer Biomarkers Market: Profiling Technology

    1. Introduction
    2. Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
    3. Proteomics: Market Trends, Size, and Forecast (2017-2026)
    4. Genomics: Market Trends, Size, and Forecast (2017-2026)

      1. Next-Generation Sequencing (NGS)
      2. Polymerase Chain Reaction (PCR)
    5. Other Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
    6. Imaging Technologies: Market Trends, Size, and Forecast (2017-2026)

      1. Ultrasound
      2. Computed Tomography (Ct)
      3. Magnetic Resonance Imaging (Mri)
      4. Positron Emission Tomography (Pet)
      5. Mammography
    7. Immunoassays: Market Trends, Size, and Forecast (2017-2026)
    8. Cytogenetics: Market Trends, Size, and Forecast (2017-2026)

      1. in Situ Hybridization (Ish)
      2. Other Cytogenetics-Based Tests
    9. Bioinformatics: Market Trends, Size, and Forecast (2017-2026)
  8. Cancer Biomarkers Market: Application

    1. Introduction
    2. Diagnostics: Market Trends, Size, and Forecast (2017-2026)
    3. Research and Development: Market Trends, Size, and Forecast (2017-2026)
    4. Prognostics: Market Trends, Size, and Forecast (2017-2026)
    5. Risk Assessment: Market Trends, Size, and Forecast (2017-2026)
    6. Other Applications: Market Trends, Size, and Forecast (2017-2026)
  9. Global Analysis

    1. Global Cancer Biomarkers Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  10. North America Analysis

    1. North America Cancer Biomarkers Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Cancer Biomarkers Market: Biomarker Type
        3. United States Cancer Biomarkers Market: Cancer Type
        4. United States Cancer Biomarkers Market: Profiling Technology
        5. United States Cancer Biomarkers Market: Application
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Cancer Biomarkers Market: Biomarker Type
        3. Canada Cancer Biomarkers Market: Cancer Type
        4. Canada Cancer Biomarkers Market: Profiling Technology
        5. Canada Cancer Biomarkers Market: Application
    2. North America Cancer Biomarkers Market, By Biomarker Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Protein Biomarkers: Market Trends, Size, and Forecast (2017-2026)
      3. Genetic Biomarkers: Market Trends, Size, and Forecast (2017-2026)

        1. Lung Cancer
        2. Colorectal Cancer
        3. Breast Cancer
        4. Prostate Cancer
        5. Leukemia
      4. Other Cancer Biomarkers: Market Trends, Size, and Forecast (2017-2026)
    3. North America Cancer Biomarkers Market, By Cancer Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Breast Cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Lung Cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Colorectal Cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Prostate Cancer: Market Trends, Size, and Forecast (2017-2026)
      6. Non-Hodgkin’s Lymphoma: Market Trends, Size, and Forecast (2017-2026)
      7. Melanoma: Market Trends, Size, and Forecast (2017-2026)
      8. Leukemia: Market Trends, Size, and Forecast (2017-2026)
      9. Thyroid Cancer: Market Trends, Size, and Forecast (2017-2026)
      10. Bladder Cancer: Market Trends, Size, and Forecast (2017-2026)
      11. Kidney Cancer: Market Trends, Size, and Forecast (2017-2026)
      12. Other Cancer Types: Market Trends, Size, and Forecast (2017-2026)
    4. North America Cancer Biomarkers Market, By Profiling Technology, Y-O-Y Growth Analysis

      1. Introduction
      2. Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      3. Proteomics: Market Trends, Size, and Forecast (2017-2026)
      4. Genomics: Market Trends, Size, and Forecast (2017-2026)

        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
      5. Other Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      6. Imaging Technologies: Market Trends, Size, and Forecast (2017-2026)

        1. Ultrasound
        2. Computed Tomography (Ct)
        3. Magnetic Resonance Imaging (Mri)
        4. Positron Emission Tomography (Pet)
        5. Mammography
      7. Immunoassays: Market Trends, Size, and Forecast (2017-2026)
      8. Cytogenetics: Market Trends, Size, and Forecast (2017-2026)

        1. in Situ Hybridization (Ish)
        2. Other Cytogenetics-Based Tests
      9. Bioinformatics: Market Trends, Size, and Forecast (2017-2026)
    5. North America Cancer Biomarkers Market, By Application, Y-O-Y Growth Analysis

      1. Introduction
      2. Diagnostics: Market Trends, Size, and Forecast (2017-2026)
      3. Research and Development: Market Trends, Size, and Forecast (2017-2026)
      4. Prognostics: Market Trends, Size, and Forecast (2017-2026)
      5. Risk Assessment: Market Trends, Size, and Forecast (2017-2026)
      6. Other Applications: Market Trends, Size, and Forecast (2017-2026)
  11. Europe Analysis

    1. Europe Cancer Biomarkers Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Cancer Biomarkers Market: Biomarker Type
        3. Germany Cancer Biomarkers Market: Cancer Type
        4. Germany Cancer Biomarkers Market: Profiling Technology
        5. Germany Cancer Biomarkers Market: Application
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Cancer Biomarkers Market: Biomarker Type
        3. United Kingdom Cancer Biomarkers Market: Cancer Type
        4. United Kingdom Cancer Biomarkers Market: Profiling Technology
        5. United Kingdom Cancer Biomarkers Market: Application
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Cancer Biomarkers Market: Biomarker Type
        3. France Cancer Biomarkers Market: Cancer Type
        4. France Cancer Biomarkers Market: Profiling Technology
        5. France Cancer Biomarkers Market: Application
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Cancer Biomarkers Market: Biomarker Type
        3. Spain Cancer Biomarkers Market: Cancer Type
        4. Spain Cancer Biomarkers Market: Profiling Technology
        5. Spain Cancer Biomarkers Market: Application
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Cancer Biomarkers Market: Biomarker Type
        3. Russia Cancer Biomarkers Market: Cancer Type
        4. Russia Cancer Biomarkers Market: Profiling Technology
        5. Russia Cancer Biomarkers Market: Application
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Cancer Biomarkers Market: Biomarker Type
        3. Italy Cancer Biomarkers Market: Cancer Type
        4. Italy Cancer Biomarkers Market: Profiling Technology
        5. Italy Cancer Biomarkers Market: Application
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Cancer Biomarkers Market: Biomarker Type
        3. Rest of Europe Cancer Biomarkers Market: Cancer Type
        4. Rest of Europe Cancer Biomarkers Market: Profiling Technology
        5. Rest of Europe Cancer Biomarkers Market: Application
    2. Europe Cancer Biomarkers Market, By Biomarker Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Protein Biomarkers: Market Trends, Size, and Forecast (2017-2026)
      3. Genetic Biomarkers: Market Trends, Size, and Forecast (2017-2026)

        1. Lung Cancer
        2. Colorectal Cancer
        3. Breast Cancer
        4. Prostate Cancer
        5. Leukemia
      4. Other Cancer Biomarkers: Market Trends, Size, and Forecast (2017-2026)
    3. Europe Cancer Biomarkers Market, By Cancer Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Breast Cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Lung Cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Colorectal Cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Prostate Cancer: Market Trends, Size, and Forecast (2017-2026)
      6. Non-Hodgkin’s Lymphoma: Market Trends, Size, and Forecast (2017-2026)
      7. Melanoma: Market Trends, Size, and Forecast (2017-2026)
      8. Leukemia: Market Trends, Size, and Forecast (2017-2026)
      9. Thyroid Cancer: Market Trends, Size, and Forecast (2017-2026)
      10. Bladder Cancer: Market Trends, Size, and Forecast (2017-2026)
      11. Kidney Cancer: Market Trends, Size, and Forecast (2017-2026)
      12. Other Cancer Types: Market Trends, Size, and Forecast (2017-2026)
    4. Europe Cancer Biomarkers Market, By Profiling Technology, Y-O-Y Growth Analysis

      1. Introduction
      2. Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      3. Proteomics: Market Trends, Size, and Forecast (2017-2026)
      4. Genomics: Market Trends, Size, and Forecast (2017-2026)

        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
      5. Other Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      6. Imaging Technologies: Market Trends, Size, and Forecast (2017-2026)

        1. Ultrasound
        2. Computed Tomography (Ct)
        3. Magnetic Resonance Imaging (Mri)
        4. Positron Emission Tomography (Pet)
        5. Mammography
      7. Immunoassays: Market Trends, Size, and Forecast (2017-2026)
      8. Cytogenetics: Market Trends, Size, and Forecast (2017-2026)

        1. in Situ Hybridization (Ish)
        2. Other Cytogenetics-Based Tests
      9. Bioinformatics: Market Trends, Size, and Forecast (2017-2026)
    5. Europe Cancer Biomarkers Market, By Application, Y-O-Y Growth Analysis

      1. Introduction
      2. Diagnostics: Market Trends, Size, and Forecast (2017-2026)
      3. Research and Development: Market Trends, Size, and Forecast (2017-2026)
      4. Prognostics: Market Trends, Size, and Forecast (2017-2026)
      5. Risk Assessment: Market Trends, Size, and Forecast (2017-2026)
      6. Other Applications: Market Trends, Size, and Forecast (2017-2026)
  12. Asia-Pacific Analysis

    1. Asia-Pacific Cancer Biomarkers Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Cancer Biomarkers Market: Biomarker Type
        3. China Cancer Biomarkers Market: Cancer Type
        4. China Cancer Biomarkers Market: Profiling Technology
        5. China Cancer Biomarkers Market: Application
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Cancer Biomarkers Market: Biomarker Type
        3. Japan Cancer Biomarkers Market: Cancer Type
        4. Japan Cancer Biomarkers Market: Profiling Technology
        5. Japan Cancer Biomarkers Market: Application
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Cancer Biomarkers Market: Biomarker Type
        3. India Cancer Biomarkers Market: Cancer Type
        4. India Cancer Biomarkers Market: Profiling Technology
        5. India Cancer Biomarkers Market: Application
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Cancer Biomarkers Market: Biomarker Type
        3. Southeast Asia Cancer Biomarkers Market: Cancer Type
        4. Southeast Asia Cancer Biomarkers Market: Profiling Technology
        5. Southeast Asia Cancer Biomarkers Market: Application
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Cancer Biomarkers Market: Biomarker Type
        3. Australia & New Zealand Cancer Biomarkers Market: Cancer Type
        4. Australia & New Zealand Cancer Biomarkers Market: Profiling Technology
        5. Australia & New Zealand Cancer Biomarkers Market: Application
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Cancer Biomarkers Market: Biomarker Type
        3. Rest of Asia-Pacific Cancer Biomarkers Market: Cancer Type
        4. Rest of Asia-Pacific Cancer Biomarkers Market: Profiling Technology
        5. Rest of Asia-Pacific Cancer Biomarkers Market: Application
    2. Asia-Pacific Cancer Biomarkers Market, By Biomarker Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Protein Biomarkers: Market Trends, Size, and Forecast (2017-2026)
      3. Genetic Biomarkers: Market Trends, Size, and Forecast (2017-2026)

        1. Lung Cancer
        2. Colorectal Cancer
        3. Breast Cancer
        4. Prostate Cancer
        5. Leukemia
      4. Other Cancer Biomarkers: Market Trends, Size, and Forecast (2017-2026)
    3. Asia-Pacific Cancer Biomarkers Market, By Cancer Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Breast Cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Lung Cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Colorectal Cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Prostate Cancer: Market Trends, Size, and Forecast (2017-2026)
      6. Non-Hodgkin’s Lymphoma: Market Trends, Size, and Forecast (2017-2026)
      7. Melanoma: Market Trends, Size, and Forecast (2017-2026)
      8. Leukemia: Market Trends, Size, and Forecast (2017-2026)
      9. Thyroid Cancer: Market Trends, Size, and Forecast (2017-2026)
      10. Bladder Cancer: Market Trends, Size, and Forecast (2017-2026)
      11. Kidney Cancer: Market Trends, Size, and Forecast (2017-2026)
      12. Other Cancer Types: Market Trends, Size, and Forecast (2017-2026)
    4. Asia-Pacific Cancer Biomarkers Market, By Profiling Technology, Y-O-Y Growth Analysis

      1. Introduction
      2. Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      3. Proteomics: Market Trends, Size, and Forecast (2017-2026)
      4. Genomics: Market Trends, Size, and Forecast (2017-2026)

        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
      5. Other Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      6. Imaging Technologies: Market Trends, Size, and Forecast (2017-2026)

        1. Ultrasound
        2. Computed Tomography (Ct)
        3. Magnetic Resonance Imaging (Mri)
        4. Positron Emission Tomography (Pet)
        5. Mammography
      7. Immunoassays: Market Trends, Size, and Forecast (2017-2026)
      8. Cytogenetics: Market Trends, Size, and Forecast (2017-2026)

        1. in Situ Hybridization (Ish)
        2. Other Cytogenetics-Based Tests
      9. Bioinformatics: Market Trends, Size, and Forecast (2017-2026)
    5. Asia-Pacific Cancer Biomarkers Market, By Application, Y-O-Y Growth Analysis

      1. Introduction
      2. Diagnostics: Market Trends, Size, and Forecast (2017-2026)
      3. Research and Development: Market Trends, Size, and Forecast (2017-2026)
      4. Prognostics: Market Trends, Size, and Forecast (2017-2026)
      5. Risk Assessment: Market Trends, Size, and Forecast (2017-2026)
      6. Other Applications: Market Trends, Size, and Forecast (2017-2026)
  13. Latin America Analysis

    1. Latin America Cancer Biomarkers Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Cancer Biomarkers Market: Biomarker Type
        3. Brazil Cancer Biomarkers Market: Cancer Type
        4. Brazil Cancer Biomarkers Market: Profiling Technology
        5. Brazil Cancer Biomarkers Market: Application
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Cancer Biomarkers Market: Biomarker Type
        3. Argentina Cancer Biomarkers Market: Cancer Type
        4. Argentina Cancer Biomarkers Market: Profiling Technology
        5. Argentina Cancer Biomarkers Market: Application
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Cancer Biomarkers Market: Biomarker Type
        3. Mexico Cancer Biomarkers Market: Cancer Type
        4. Mexico Cancer Biomarkers Market: Profiling Technology
        5. Mexico Cancer Biomarkers Market: Application
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Cancer Biomarkers Market: Biomarker Type
        3. Colombia Cancer Biomarkers Market: Cancer Type
        4. Colombia Cancer Biomarkers Market: Profiling Technology
        5. Colombia Cancer Biomarkers Market: Application
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Cancer Biomarkers Market: Biomarker Type
        3. Rest of Latin America Cancer Biomarkers Market: Cancer Type
        4. Rest of Latin America Cancer Biomarkers Market: Profiling Technology
        5. Rest of Latin America Cancer Biomarkers Market: Application
    2. Latin America Cancer Biomarkers Market, By Biomarker Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Protein Biomarkers: Market Trends, Size, and Forecast (2017-2026)
      3. Genetic Biomarkers: Market Trends, Size, and Forecast (2017-2026)

        1. Lung Cancer
        2. Colorectal Cancer
        3. Breast Cancer
        4. Prostate Cancer
        5. Leukemia
      4. Other Cancer Biomarkers: Market Trends, Size, and Forecast (2017-2026)
    3. Latin America Cancer Biomarkers Market, By Cancer Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Breast Cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Lung Cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Colorectal Cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Prostate Cancer: Market Trends, Size, and Forecast (2017-2026)
      6. Non-Hodgkin’s Lymphoma: Market Trends, Size, and Forecast (2017-2026)
      7. Melanoma: Market Trends, Size, and Forecast (2017-2026)
      8. Leukemia: Market Trends, Size, and Forecast (2017-2026)
      9. Thyroid Cancer: Market Trends, Size, and Forecast (2017-2026)
      10. Bladder Cancer: Market Trends, Size, and Forecast (2017-2026)
      11. Kidney Cancer: Market Trends, Size, and Forecast (2017-2026)
      12. Other Cancer Types: Market Trends, Size, and Forecast (2017-2026)
    4. Latin America Cancer Biomarkers Market, By Profiling Technology, Y-O-Y Growth Analysis

      1. Introduction
      2. Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      3. Proteomics: Market Trends, Size, and Forecast (2017-2026)
      4. Genomics: Market Trends, Size, and Forecast (2017-2026)

        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
      5. Other Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      6. Imaging Technologies: Market Trends, Size, and Forecast (2017-2026)

        1. Ultrasound
        2. Computed Tomography (Ct)
        3. Magnetic Resonance Imaging (Mri)
        4. Positron Emission Tomography (Pet)
        5. Mammography
      7. Immunoassays: Market Trends, Size, and Forecast (2017-2026)
      8. Cytogenetics: Market Trends, Size, and Forecast (2017-2026)

        1. in Situ Hybridization (Ish)
        2. Other Cytogenetics-Based Tests
      9. Bioinformatics: Market Trends, Size, and Forecast (2017-2026)
    5. Latin America Cancer Biomarkers Market, By Application, Y-O-Y Growth Analysis

      1. Introduction
      2. Diagnostics: Market Trends, Size, and Forecast (2017-2026)
      3. Research and Development: Market Trends, Size, and Forecast (2017-2026)
      4. Prognostics: Market Trends, Size, and Forecast (2017-2026)
      5. Risk Assessment: Market Trends, Size, and Forecast (2017-2026)
      6. Other Applications: Market Trends, Size, and Forecast (2017-2026)
  14. Middle East & Africa Analysis

    1. Middle East & Africa Cancer Biomarkers Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Cancer Biomarkers Market: Biomarker Type
        3. Middle East Cancer Biomarkers Market: Cancer Type
        4. Middle East Cancer Biomarkers Market: Profiling Technology
        5. Middle East Cancer Biomarkers Market: Application
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Cancer Biomarkers Market: Biomarker Type
        3. Africa Cancer Biomarkers Market: Cancer Type
        4. Africa Cancer Biomarkers Market: Profiling Technology
        5. Africa Cancer Biomarkers Market: Application
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Cancer Biomarkers Market: Biomarker Type
        3. Rest of Middle East & Africa Cancer Biomarkers Market: Cancer Type
        4. Rest of Middle East & Africa Cancer Biomarkers Market: Profiling Technology
        5. Rest of Middle East & Africa Cancer Biomarkers Market: Application
    2. Middle East & Africa Cancer Biomarkers Market, By Biomarker Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Protein Biomarkers: Market Trends, Size, and Forecast (2017-2026)
      3. Genetic Biomarkers: Market Trends, Size, and Forecast (2017-2026)

        1. Lung Cancer
        2. Colorectal Cancer
        3. Breast Cancer
        4. Prostate Cancer
        5. Leukemia
      4. Other Cancer Biomarkers: Market Trends, Size, and Forecast (2017-2026)
    3. Middle East & Africa Cancer Biomarkers Market, By Cancer Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Breast Cancer: Market Trends, Size, and Forecast (2017-2026)
      3. Lung Cancer: Market Trends, Size, and Forecast (2017-2026)
      4. Colorectal Cancer: Market Trends, Size, and Forecast (2017-2026)
      5. Prostate Cancer: Market Trends, Size, and Forecast (2017-2026)
      6. Non-Hodgkin’s Lymphoma: Market Trends, Size, and Forecast (2017-2026)
      7. Melanoma: Market Trends, Size, and Forecast (2017-2026)
      8. Leukemia: Market Trends, Size, and Forecast (2017-2026)
      9. Thyroid Cancer: Market Trends, Size, and Forecast (2017-2026)
      10. Bladder Cancer: Market Trends, Size, and Forecast (2017-2026)
      11. Kidney Cancer: Market Trends, Size, and Forecast (2017-2026)
      12. Other Cancer Types: Market Trends, Size, and Forecast (2017-2026)
    4. Middle East & Africa Cancer Biomarkers Market, By Profiling Technology, Y-O-Y Growth Analysis

      1. Introduction
      2. Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      3. Proteomics: Market Trends, Size, and Forecast (2017-2026)
      4. Genomics: Market Trends, Size, and Forecast (2017-2026)

        1. Next-Generation Sequencing (NGS)
        2. Polymerase Chain Reaction (PCR)
      5. Other Omics Technologies: Market Trends, Size, and Forecast (2017-2026)
      6. Imaging Technologies: Market Trends, Size, and Forecast (2017-2026)

        1. Ultrasound
        2. Computed Tomography (Ct)
        3. Magnetic Resonance Imaging (Mri)
        4. Positron Emission Tomography (Pet)
        5. Mammography
      7. Immunoassays: Market Trends, Size, and Forecast (2017-2026)
      8. Cytogenetics: Market Trends, Size, and Forecast (2017-2026)

        1. in Situ Hybridization (Ish)
        2. Other Cytogenetics-Based Tests
      9. Bioinformatics: Market Trends, Size, and Forecast (2017-2026)
    5. Middle East & Africa Cancer Biomarkers Market, By Application, Y-O-Y Growth Analysis

      1. Introduction
      2. Diagnostics: Market Trends, Size, and Forecast (2017-2026)
      3. Research and Development: Market Trends, Size, and Forecast (2017-2026)
      4. Prognostics: Market Trends, Size, and Forecast (2017-2026)
      5. Risk Assessment: Market Trends, Size, and Forecast (2017-2026)
      6. Other Applications: Market Trends, Size, and Forecast (2017-2026)
  15. Cancer Biomarkers Market: Company Analysis

    1. Introduction
    2. Thermo Fisher Scientific

      1. Overview
      2. Business Portfolio
      3. Product Portfolio
      4. Key Brands Insights
      5. Company SWOT & Strategic Analysis
      6. Company Financials
      7. Analyst Insights
    3. Bio-Rad Laboratories

    4. Roche Diagnostics

    5. Qiagen N.V.

    6. Illumina

    7. GE Healthcare

    8. Agilent Technologies

    9. Biomérieux SA

    10. Merck & Co.

    11. Abbott Laboratories

    12. Becton, Dickinson and Company

    13. Danaher Corporation

    14. Myriad Genetics

    15. Sysmex Corporation

    16. Hologic

    17. Quest Diagnostics

  16. Cancer Biomarkers Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  17. Cancer Biomarkers Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  18. Industry & Analysts Insights for Success

  19. Research Methodology

  20. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures

Figure 1: Global Cancer Biomarkers Market: Structure

Figure 2: Global Cancer Biomarkers Market: Value Chain Analysis

Figure 3: Global Cancer Biomarkers Market: Porter's Five Forces Model

Figure 4: Global Cancer Biomarkers Market: Market Dynamics

Figure 5: Global Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Figure 6: Global Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Figure 7: Global Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Figure 8: Global Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Figure 9: Global Cancer Biomarkers Market, By Region, 2016-2026 (USD Million)

Figure 10: North America Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Figure 11: North America Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Figure 12: North America Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Figure 13: North America Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Figure 14: North America Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Figure 15: Europe Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Figure 16: Europe Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Figure 17: Europe Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Figure 18: Europe Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Figure 19: Europe Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Figure 20: Asia-Pacific Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Figure 21: Asia-Pacific Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Figure 22: Asia-Pacific Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Figure 23: Asia-Pacific Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Figure 24: Asia-Pacific Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Figure 25: Latin America Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Figure 26: Latin America Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Figure 27: Latin America Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Figure 28: Latin America Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Figure 29: Latin America Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Figure 30: Middle East & Africa Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Figure 31: Middle East & Africa Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Figure 32: Middle East & Africa Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Figure 33: Middle East & Africa Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Figure 34: Middle East & Africa Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

List of Tables

Table 1: Global Cancer Biomarkers Market, By Biomarker Type, 2017-2026 (USD Million)

Table 2: Global Cancer Biomarkers Market, By Cancer Type, 2017-2026 (USD Million)

Table 3: Global Cancer Biomarkers Market, By Profiling Technology, 2017-2026 (USD Million)

Table 4: Global Cancer Biomarkers Market, By Application, 2017-2026 (USD Million)

Table 5: Global Cancer Biomarkers Market, By Region, 2017-2026 (USD Million)

Table 6: North America Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 7: North America Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 8: North America Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 9: North America Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 10: North America Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Table 11: United States Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 12: United States Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 13: United States Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 14: United States Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 15: Canada Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 16: Canada Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 17: Canada Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 18: Canada Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 19: Europe Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 20: Europe Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 21: Europe Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 22: Europe Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 23: Europe Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Table 24: Germany Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 25: Germany Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 26: Germany Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 27: Germany Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 28: United Kingdom Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 29: United Kingdom Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 30: United Kingdom Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 31: United Kingdom Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 32: France Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 33: France Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 34: France Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 35: France Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 36: Spain Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 37: Spain Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 38: Spain Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 39: Spain Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 40: Russia Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 41: Russia Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 42: Russia Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 43: Russia Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 44: Italy Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 45: Italy Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 46: Italy Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 47: Italy Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 48: Rest of Europe Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 49: Rest of Europe Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 50: Rest of Europe Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 51: Rest of Europe Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 52: Asia-Pacific Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 53: Asia-Pacific Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 54: Asia-Pacific Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 55: Asia-Pacific Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 56: Asia-Pacific Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Table 57: China Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 58: China Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 59: China Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 60: China Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 61: Japan Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 62: Japan Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 63: Japan Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 64: Japan Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 65: India Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 66: India Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 67: India Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 68: India Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 69: Southeast Asia Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 70: Southeast Asia Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 71: Southeast Asia Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 72: Southeast Asia Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 73: Australia & New Zealand Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 74: Australia & New Zealand Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 75: Australia & New Zealand Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 76: Australia & New Zealand Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 77: Rest of Asia-Pacific Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 78: Rest of Asia-Pacific Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 79: Rest of Asia-Pacific Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 80: Rest of Asia-Pacific Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 81: Latin America Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 82: Latin America Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 83: Latin America Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 84: Latin America Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 85: Latin America Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Table 86: Brazil Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 87: Brazil Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 88: Brazil Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 89: Brazil Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 90: Argentina Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 91: Argentina Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 92: Argentina Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 93: Argentina Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 94: Mexico Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 95: Mexico Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 96: Mexico Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 97: Mexico Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 98: Colombia Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 99: Colombia Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 100: Colombia Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 101: Colombia Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 102: Rest of Latin America Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 103: Rest of Latin America Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 104: Rest of Latin America Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 105: Rest of Latin America Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 106: Middle East & Africa Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 107: Middle East & Africa Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 108: Middle East & Africa Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 109: Middle East & Africa Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 110: Middle East & Africa Cancer Biomarkers Market, By Country, 2016-2026 (USD Million)

Table 111: Middle East Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 112: Middle East Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 113: Middle East Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 114: Middle East Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 115: Africa Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 116: Africa Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 117: Africa Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 118: Africa Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)

Table 119: Rest of Middle East & Africa Cancer Biomarkers Market, By Biomarker Type, 2016-2026 (USD Million)

Table 120: Rest of Middle East & Africa Cancer Biomarkers Market, By Cancer Type, 2016-2026 (USD Million)

Table 121: Rest of Middle East & Africa Cancer Biomarkers Market, By Profiling Technology, 2016-2026 (USD Million)

Table 122: Rest of Middle East & Africa Cancer Biomarkers Market, By Application, 2016-2026 (USD Million)